Infinity Pharmaceuticals Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
56.85 M |
Public Float |
41.97 M |
Infinity Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.27 |
Market Cap |
$98.48 M |
Shares Outstanding |
56.93 M |
Public Float |
54.87 M |
Address |
784 Memorial Drive Cambridge Massachusetts 02139 United States |
Employees | - |
Website | http://www.infi.com |
Updated | 07/08/2019 |
Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA. |